IRIS - Res&Arch Institutional Research Information System - Research & Archive

CAMILLONI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.628
EU - Europa 1.804
AS - Asia 1.165
OC - Oceania 6
AF - Africa 4
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.614
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.598
IE - Irlanda 522
UA - Ucraina 429
SG - Singapore 397
VN - Vietnam 291
HK - Hong Kong 260
IT - Italia 242
FI - Finlandia 129
CN - Cina 123
DE - Germania 118
SE - Svezia 107
RU - Federazione Russa 90
GB - Regno Unito 37
KR - Corea 37
TR - Turchia 33
AT - Austria 22
BE - Belgio 22
FR - Francia 22
CA - Canada 20
CH - Svizzera 16
PT - Portogallo 12
MX - Messico 9
NL - Olanda 9
LB - Libano 8
UZ - Uzbekistan 8
AU - Australia 6
GR - Grecia 6
CZ - Repubblica Ceca 5
PL - Polonia 5
GH - Ghana 4
BR - Brasile 3
EU - Europa 3
RO - Romania 3
JP - Giappone 2
LT - Lituania 2
SA - Arabia Saudita 2
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CR - Costa Rica 1
ES - Italia 1
ID - Indonesia 1
IL - Israele 1
IN - India 1
LV - Lettonia 1
NO - Norvegia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.614
Salva come PNG Salva come JPEG
Città #
Chandler 541
Dublin 521
Singapore 337
Dong Ket 290
Hong Kong 260
San Mateo 240
Jacksonville 238
Boardman 166
Santa Clara 131
Medford 115
Princeton 115
Wilmington 82
Perugia 78
Andover 73
Ann Arbor 72
Ashburn 64
Beijing 55
Altamura 38
Helsinki 36
Izmir 33
Lawrence 32
Saint Petersburg 28
Des Moines 24
Genoa 23
Munich 22
Falls Church 21
Norwalk 21
Seoul 21
Ottawa 20
Redwood City 18
Rome 18
Redmond 17
Vienna 16
Los Angeles 15
Dongjak-gu 14
Brussels 13
Houston 10
Terni 10
Woodbridge 9
Moscow 7
Corciano 6
Den Haag 6
Longueville 6
New York 6
Porto 6
Shanghai 6
Frankfurt am Main 5
Gualdo Cattaneo 5
San Paolo di Civitate 5
Dallas 4
London 4
Seattle 4
Belfiore 3
Fairfield 3
Hanover 3
Heusden 3
Sona 3
Amsterdam 2
Cuernavaca 2
Dearborn 2
Esslingen am Neckar 2
Faenza 2
Fortaleza 2
Lappeenranta 2
Macerata 2
Menlo Park 2
Milan 2
Monticiano 2
Nanjing 2
Pesaro 2
Pistoia 2
Riyadh 2
Sacheon-si 2
Sinalunga 2
Timisoara 2
Turin 2
Abbadia 1
Andra 1
Assisi 1
Auburn Hills 1
Baku 1
Belo Horizonte 1
Bethesda 1
Bognor Regis 1
Bratislava 1
Brooklyn 1
Bucharest 1
Buenos Aires 1
Cambridge 1
Changsha 1
Chengdu 1
Costa Mesa 1
Creazzo 1
Espoo 1
Florence 1
Frankfurt Am Main 1
Fremont 1
Gunzenhausen 1
Hangzhou 1
Hanoi 1
Totale 3.984
Salva come PNG Salva come JPEG
Nome #
10-Year Rotavirus Infection Surveillance: Epidemiological Trends in the Pediatric Population of Perugia Province 145
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 91
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial 89
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 83
Molecular analysis of Group of Rotaviruses detected in subjects with severe acute gastroenteritis in Umbria from 2006 to 2012 80
Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis 80
Annually repeated influenza vaccination and humoral response in elderly volunteers. 77
Antibodies cross-reactive to seasonal influenza A(H1N1)pdm09 viruses in human sera of elderly people immunized with trivalent influenza vaccines containing the A/California/7/09 vaccine strain 75
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59 adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. 72
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 71
L’influenza in Umbria nell’inverno 2005/06 69
Influenza vaccination in patients on long-term anticoagulant therapy. 69
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 67
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 66
A G12P[8] rotavirus gastroenteritis outbreak in Italy, 2013 66
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature 65
Accelerate Pheno™ blood culture detection system: a literature review 65
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 63
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 62
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 62
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 62
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 61
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 61
A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60–85 years old) and very elderly (>85 years old) institutionalized subjects 61
Influenza vaccination in patients on long-term anticoagulant therapy 61
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages 60
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 60
A novel methodology based on serological data for improving precision in the influenza vaccine response of non-seroprotected 60
An influenza outbreak in elderly vaccinated people in the winter season 2007/2008 57
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 57
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 57
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 57
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 56
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 56
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 56
Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility 55
Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulatingA(H3N2)strains 55
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 54
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 53
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 52
Flow cytometric analysis of intracellular antigen-specific interferon-gamma in human NK and T populations after influenza vaccination 51
L'influenza: sistemi di sorveglianza e campagne vaccinali 50
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 50
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 50
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 50
Vaccination against paediatric respiratory pathogens 50
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 49
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 49
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 49
Detection of Unusual G6 Rotavirus Strains in Italian Children With Diarrhoea During the 2011 Surveillance Season 49
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 49
Vaccinazione antinfluenzale in soggetti HIV-1 positivi trattati con HAART: influenza sulla risposta anticorpale della concentrazione plasmatici di HIV-1 RNA e del numero di CD4+ 48
Cross-reactive antibodies to viruses of both B/Victoria and B/Yamagata lineages as induced by influenza vaccination in middle-aged and elderly volunteers 48
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 48
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 48
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age 47
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 47
First detection of a reassortant G3P[8] rotavirus Astrain in Italy: a case report in an 8-year-old child 47
Declined antibody response following influenza vaccination in elderly as compared with middle-aged volunteers: effects of aging and/or original antigenic sin? 46
Immunization with adjuvanted and non-adjuvanted influenza vaccines of HIV-1 positive patients treated with highly active antiretroviral therapy (HAART) 46
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 46
UN MAGGIORE UTILIZZO DI SIERI UMANI PUO’ CONTRIBUIRE AD UNA MIGLIORE CARATTERIZZAZIONE ANTIGENICA DEI VIRUS INFLUENZALI PER LA SCELTA DELLE COMPONENTI VACCINALI 45
Immunogenicity of subunit and split influenza vaccines and serologically diagnosed influenza infections after vaccination in elderly instituzionalized volunteers (winter season 1999/200) 44
Intracellular influenza antigen-specific cytokines in human T and NK population after influenza vaccination 43
Sorveglianza delle paralisi flaccide acute nella regione Umbria 43
Multiplex platforms for the identification of respiratory pathogens: Are they useful in pediatric clinical practice? 43
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 42
Hospital‐acquired rotavirus acute gastroenteritis in 10 consecutive seasons in Umbria (Italy) 42
Flow cytometric measurement of influenza-antigens intracellular interferon gamma induction in aged subjects before and after 2001/02 influenza vaccination 41
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 41
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection 41
Immunogenicità ed efficacia protettiva del vaccino influenzale per l’inverno 2007/08 in soggetti residenti in casa di riposo 40
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 40
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 40
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winter seasons 39
Inhibitor development in mild/moderate haemophilia: could influenza vaccination have been the trigger? 39
Unexpected spreading of G12P[8] rotavirus strains among young children in a small area of central Italy 39
Drugs for Influenza Treatment: Is There Significant News? 39
Role of nucleocapsid protein antigen detection for safe end of isolation of sars-cov-2 infected patients with long persistence of viral rna in respiratory samples 39
Increased immunogenicity of an adjuvanted influenza vaccine compared with a conventional subunit vaccine in non-elderly adult HIV seropositive individuals, treated with HAART 38
Twenty-seven years experience with immunogenicity of inactivated influenza vaccines in the elderly 38
Accuracy and impact on patient management of new tools for diagnosis of sepsis: Experience with the t2 magnetic resonance bacteria panel 38
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and elderly volunteers (winter season 2003/2004) 37
Laboratory confirmed pandemic H1N1 influenza virus infections in hospitalization in Umbria, a region of central Italy (May-November 2009). 37
Soggetti ricoverati in ospedale in Umbria con diagnosi di laboratorio di infezione da virus influenzale pandemico A/H1N1 nel periodo Luglio 2009 - Marzo 2010 37
Molecular Analysis of Group A Rotaviruses Detected in Adults and Adolescents With Severe Acute Gastroenteritis in Italy in 2012 37
Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017 37
Serologically diagnosed influenza virus A/California/7/04 (H3N2)infection in people immunised with A/Fujan/411/2002(H3N2)antigen during the 2004/05 winter season 36
Induzione di anticorpi omologhi e cross-reattivi nei confronti di virus influenzali di tipo B da parte del vaccino influenzale nell'inverno 2003/2004 36
Efficacy of an inactivated influenza vaccine among well immunized nursing home residents during the 2007/2008 season 36
Seroprevalence to the 2009 pandemic influenza a(H1N1) virus in the italian population after the 2009 pandemic (September/November 2010) 36
Serological methods are able to determine how well influenza vaccines work 36
Design and validation of a self-administered questionnaire to assess knowledge, attitudes and behaviours about Zika virus infection among general population in Italy. A pilot study conducted among Italian residents in public health 36
Influenza B virus circulation in elderly vaccinated people living in a nursing home in the winter season 2007/2008 35
Effect of age on serum heterologous antibody response elicited by inactivated influenza virus vaccine 35
INHIBITOR DEVELOPMENT IN MILD HAEMOPHILIA A: COULD INFLUENZA VACCINATION HAVE BEEN THE TRIGGER? 35
Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review 35
Influenza vaccination in patients on long-term anticoagulant therapy 34
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate 34
Influenza vaccine induction of cross-reactive antibodies against different B/Yamagata and B/Vicotria-like influenza viruses 33
Totale 5.181
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.823
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020269 0 0 0 0 0 1 62 24 76 59 8 39
2020/20211.054 14 69 16 75 273 42 88 10 75 18 70 304
2021/2022825 17 152 6 21 31 16 7 308 15 14 103 135
2022/20231.622 119 176 14 144 125 181 3 83 694 5 54 24
2023/2024766 70 67 40 15 7 4 183 33 114 20 121 92
2024/2025757 25 195 58 87 308 84 0 0 0 0 0 0
Totale 5.852